YANG LOU

Yang Lou has a wealth of experience in the biotechnology field. YANG began their career in 1999 as a Ph.D. at the University of Science and Technology of China, where they conducted studies of key regulatory protein interaction networks underlying cell proliferation, toxicological research of chemical compounds, and biological characterization of Glucose Isomerase and DNA photolyase. In 2005, they joined UMass Medical School as a Post-doctoral researcher and Instructor, where they screened rabbit monoclonal antibody for neutralizing HIV virus by single cell sorting and cloning method, studied the evaluation of function antibody in rabbit by deep sequencing, and studied the immunogenicity of DNA antigens. In 2015, they became the CEO of Yurogen Biosystems LLC, located in the Greater Boston area, where they were dedicated to producing premium antibodies and antibody-based products to meet a broad needs of their clients. Most recently, in 2021, they joined ABclonal Technology as Senior Vice President (S.V.P) and Director.

Yang Lou received a Ph.D. in Cell Biology from the University of Science and Technology of China from 1999 to 2005. Prior to that, they attended Nanjing University from 1995 to 1999.